Quantitative Systematic Strategies’s Array Biopharma Inc ARRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-8,733
| Closed | -$405K | – | 640 |
|
|
2019
Q2 | $405K | Buy |
+8,733
| New | +$245K | 0.08% | 288 |
|
|
2019
Q1 | – | Sell |
-35,249
| Closed | -$502K | – | 775 |
|
|
2018
Q4 | $502K | Buy |
35,249
+9,836
| +39% | +$149K | 0.11% | 270 |
|
|
2018
Q3 | $386K | Buy |
+25,413
| New | +$389K | 0.07% | 359 |
|
|
2018
Q2 | – | Sell |
-13,838
| Closed | -$226K | – | 860 |
|
|
2018
Q1 | $226K | Buy |
13,838
+600
| +5% | +$9.61K | 0.05% | 537 |
|
|
2017
Q4 | $169K | Buy |
+13,238
| New | +$151K | 0.04% | 507 |
|
|
2017
Q3 | – | Sell |
-12,568
| Closed | -$106K | – | 595 |
|
|
2017
Q2 | $106K | Buy |
12,568
+1,103
| +10% | +$9.02K | 0.03% | 422 |
|
|
2017
Q1 | $102K | Sell |
11,465
-655
| -5% | -$6.97K | 0.03% | 345 |
|
|
2016
Q4 | $105K | Sell |
12,120
-47,869
| -80% | -$352K | 0.04% | 285 |
|
|
2016
Q3 | $383K | Buy |
+59,989
| New | +$232K | 0.14% | 224 |
|
|
2015
Q3 | – | Sell |
-56,657
| Closed | -$400K | – | 589 |
|
|
2015
Q2 | $400K | Buy |
56,657
+6,922
| +14% | +$51.1K | 0.09% | 365 |
|
|
2015
Q1 | $375K | Buy |
+49,735
| New | +$354K | 0.1% | 323 |
|
|
2014
Q2 | – | Sell |
-24,924
| Closed | -$111K | – | 370 |
|
|
2014
Q1 | $111K | Buy |
+24,924
| New | +$125K | 0.09% | 268 |
|
Other funds holding ARRY
Quantitative Systematic Strategies's ARRY Position: Q3 2019 in Review
Quantitative Systematic Strategies sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 8,733 shares — an estimated $405K sold.
Quantitative Systematic Strategies first reported a position in ARRY in Q1 2014 and held it in 12 quarters. The position peaked at $502K in Q4 2018. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.
- Quantitative Systematic Strategies reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
- Quantitative Systematic Strategies sold 8,733 Array Biopharma Inc shares in Q3 2019, an estimated $405K.
- Quantitative Systematic Strategies first reported a position in Array Biopharma Inc in Q1 2014 and held it in 12 quarters.
- Quantitative Systematic Strategies's Array Biopharma Inc position peaked at $502K in Q4 2018.
- 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.
Based on Quantitative Systematic Strategies's 13F filing for Q3 2019, filed 7 Nov 2019.